Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 5, 2022 |
| Target | Polyganics |
| Sector | Medical Products |
| Buyer(s) | Regenity Biosciences |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Medical Products |
Regenity Biosciences is a developer and manufacturer of bioresorbable and collagen-based medical products for tissue and bone repair and regeneration in dental, orthopedic, sports medicine, neurosurgery, and related clinical areas. It supplies these products to original equipment manufacturers and provides contract product development and manufacturing services. Regenity Biosciences was founded in 1997 and is based in Paramus, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products | 2 of 2 |
| Type: Add-on Acquisition | 1 of 1 |
| Country: Netherlands | 1 of 1 |
| Year: 2022 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-29 |
Sunstar s Degradable Solutions
Schlieren, Switzerland Degradable Solutions develops and markets a high performing, synthetic portfolio of tissue regeneration products. Its GUIDOR family of bone graft substitutes, known as "easy-graft" and "calc-i-oss," as well as the GUIDOR bioresorbable matrix barrier membrane, are distributed globally for use in dental surgical and restoration procedures. Degradable Solutions was founded in 1999 and is headquartered in Schlieren, Switzerland |
Buy | - |
